How do the effects of climate change impact your work in clinical and translational science? There’s still time to register for our upcoming CLIC-hosted Un-Meeting, “Climate Change and Human Health (C2H2): Through a Translational Science Lens”, happening virtually on February 10, 2022 from 11 AM – 3:30 PM ET. Attendees will hear presentations from speakers across and […]
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic […]
The National Institutes of Health (NIH) has launched the Neuromod Prize, a $9.8 million competition to accelerate the development of targeted neuromodulation therapies. The first phase calls on scientists, engineers, and clinicians to submit novel concepts and plans for development. “Through the Neuromod Prize, we’re asking potential solvers to use the foundational knowledge and technologies that have come […]
Registration is now open for CLIC-hosted Un-Meeting! Topic: Climate Change and Human Health (C2H2): Through a Translational Science Lens When? February 10, 2022 11:00 AM – 3:30 PM ET The link between C2H2 and translational science is not intuitive for all but epidemiology, prevention, and treatment of human disease related to climate change all have translational science […]
Are you looking to pitch an idea or find out if your idea is equity fundable? Our equity investors are looking to help BU people with their ideas. An equity investor is a person with money or access to other people’s money with the intent to invest in new companies through companies’ stock/shares. We have […]
From Context to Care: Understanding the Convergence of Social Factors and Emergency Department Care Join NINR and the Emergency Nurses Association (ENA) on March 3-4 for the 2022 National Nursing Research Roundtable (NNRR). Thursday, March 3, 2022 – Keynote Address Friday, March 4, 2022 – Roundtable Discussion *Registration details coming soon Learn More
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and […]
Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed) The goal of RE-JOIN will be to define the innervation of the different articular and peri-articular tissues that collectively form the joint (including bone, cartilage, synovium, joint capsule, ligament, tendon, fascia, and muscle) by sensory neurons that mediate the sensation […]
ORWH Announces Administrative Supplements to Support Research on the Health of Women in U3 Populations ORWH has announced the availability of administrative supplements to support research highlighting health inequities among populations of women in the U.S. that are understudied, underrepresented, and underreported (U3) in biomedical research. Applications should provide robust study designs that would explore […]
Mike’s Blog December, 2021 ‘OMGodicron’ By: Michael G. Kurilla, M.D., Ph.D., NCATS Director of the Division of Clinical Innovation COVID continues to prove itself remarkably tenacious and provided a Thanksgiving surprise with a new variant of concern, omicron. For those keeping track, we’re now about two-thirds of the way through the Greek alphabet. If we […]